IL310559A - Methods for treating disorders of the nervous system with antipurinergic substances - Google Patents
Methods for treating disorders of the nervous system with antipurinergic substancesInfo
- Publication number
- IL310559A IL310559A IL310559A IL31055924A IL310559A IL 310559 A IL310559 A IL 310559A IL 310559 A IL310559 A IL 310559A IL 31055924 A IL31055924 A IL 31055924A IL 310559 A IL310559 A IL 310559A
- Authority
- IL
- Israel
- Prior art keywords
- antipurinergic
- agents
- methods
- nervous system
- system disorders
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236155P | 2021-08-23 | 2021-08-23 | |
| PCT/US2022/041050 WO2023027994A1 (en) | 2021-08-23 | 2022-08-22 | Methods for treating nervous system disorders with antipurinergic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310559A true IL310559A (en) | 2024-03-01 |
Family
ID=85321996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310559A IL310559A (en) | 2021-08-23 | 2022-08-22 | Methods for treating disorders of the nervous system with antipurinergic substances |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240277641A1 (enExample) |
| EP (1) | EP4366828A1 (enExample) |
| JP (1) | JP2024532288A (enExample) |
| CN (1) | CN118103072A (enExample) |
| AU (1) | AU2022332894A1 (enExample) |
| CA (1) | CA3227596A1 (enExample) |
| IL (1) | IL310559A (enExample) |
| WO (1) | WO2023027994A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04009310A (es) * | 2002-03-26 | 2005-01-25 | Eastern Virginia Med School | Suramin y derivados del mismo como microbicidas y contraceptivos. |
| EP2770985A4 (en) * | 2011-10-25 | 2015-01-21 | U S Phytotherapy Inc | ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| IL282156B (en) * | 2014-07-29 | 2022-07-01 | Shenzhen Hightide Biopharmaceutical Ltd | Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof |
| CN118697876A (zh) * | 2017-02-09 | 2024-09-27 | 完美日光有限公司 | 用于自闭症谱系障碍药物治疗的方法 |
| JP7749169B2 (ja) * | 2019-06-07 | 2025-10-06 | クヴァトリス セラピューティクス, インコーポレイテッド | 中枢神経系障害を処置するための組成物および方法 |
| IL302224A (en) * | 2020-10-22 | 2023-06-01 | Paxmedica Inc | Administration of anti-purinergic preparations for the treatment of disorders of the nervous system |
-
2022
- 2022-08-22 WO PCT/US2022/041050 patent/WO2023027994A1/en not_active Ceased
- 2022-08-22 JP JP2024512072A patent/JP2024532288A/ja active Pending
- 2022-08-22 IL IL310559A patent/IL310559A/en unknown
- 2022-08-22 CA CA3227596A patent/CA3227596A1/en active Pending
- 2022-08-22 EP EP22861939.1A patent/EP4366828A1/en not_active Withdrawn
- 2022-08-22 CN CN202280057126.5A patent/CN118103072A/zh active Pending
- 2022-08-22 AU AU2022332894A patent/AU2022332894A1/en active Pending
-
2024
- 2024-02-07 US US18/435,069 patent/US20240277641A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022332894A1 (en) | 2024-02-29 |
| JP2024532288A (ja) | 2024-09-05 |
| WO2023027994A1 (en) | 2023-03-02 |
| EP4366828A1 (en) | 2024-05-15 |
| CN118103072A (zh) | 2024-05-28 |
| CA3227596A1 (en) | 2023-03-02 |
| US20240277641A1 (en) | 2024-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285649A (en) | Azepino-indoles and other heterocyclics for the treatment of brain disorders | |
| IL285642A (en) | n-converted indoles and other heterocycles for the treatment of brain disorders | |
| IL290455A (en) | Methods of treating psychological and brain disorders | |
| IL267082A (en) | Systems and methods for the treatment of neurological disorders | |
| EP3746135A4 (en) | METHODS AND COMPOUNDS FOR TREATMENT OF DISEASE | |
| IL313097A (en) | Methods of treating cns disorders | |
| IL294594A (en) | Methods of treating pemphigus | |
| IL288655A (en) | Preparations and methods for the treatment of central nervous system disorders | |
| EP3810049A4 (en) | SYSTEMS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
| IL307607A (en) | Tetracyclic compounds for the treatment of brain disorders | |
| IL276358A (en) | COMPOUNDS AND METHODS FOR THE TREATMENT OF ADDICTION AND RELATED DISORDERS | |
| EP3471746A4 (en) | METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS | |
| PL3930823T3 (pl) | Układ do stymulacji mózgu, urządzenie, układ i odpowiedni sposób do leczenia afazji | |
| IL296215B2 (en) | Purine compounds for the treatment of diseases | |
| GB2605422B (en) | Treatment of the central nervous system | |
| SG11202106794WA (en) | Method for treating lower back pain | |
| HUE073483T2 (hu) | Eljárások hiperfenilalaninémia kezelésére | |
| IL313539A (en) | Methods for treating neurological disorders | |
| IL310559A (en) | Methods for treating disorders of the nervous system with antipurinergic substances | |
| IL291639A (en) | A method for treating mood disorders | |
| SG11202100767XA (en) | Methods for treating neurodegenerative disorders | |
| IL311852A (en) | Preparations and methods for the treatment of neurological disorders | |
| GB202109675D0 (en) | Treatment for tyrosine degradation-associated disorders | |
| CA3284708A1 (en) | Methods for treating nervous system disorders | |
| EP3982943A4 (en) | Combination treatments for central nervous system disorders |